Han B, Zheng R, Zeng H, Shaoming W, Kexin S et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1).
Rudin CM, Brambilla E, Faivre-Finn C, Julien S. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.
Article PubMed PubMed Central Google Scholar
Arriagada R, Le Chevalier T, Borie F, Rivière A, Chomyet P, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87:183–90.
Article CAS PubMed Google Scholar
Aupérin A, Arriagada R, Pignon JP, Péchoux C, Gregor A, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;341(7):476–84.
Seute T, Leffers P, ten Velde GP, Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI) [J]. Cancer. 2008;112(8):1827–34.
Hu X, Bao Y, Xu YJ, Hui-Neng Z, Jin-Shi L, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer. 2020;126(4):840–9.
Article CAS PubMed Google Scholar
Hu X, Bao Y, Zhang L, Ying G, YuanYuan C, et al. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial. Cancer. 2012;118(1):278–87.
Mengyuan Chen, Yongling J, Xiao H, Ming C et al. Factors affecting the risk of Brain Metastasis in Limited-Stage Small Cell Lung Cancer after prophylactic cranial irradiation. Cancer Manage Res 2022:14:1807–14.
Chu X, Li S, Xia B, Li C, Xi Y, et al. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer. Radiat Oncol. 2019;14(1):171.
Article PubMed PubMed Central Google Scholar
Manapov F, Klautke G, Fietkau R. Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol. 2008;3(6):652–5.
Qing W, Mengyuan C, Fang P, Qun Z, Yue K, et al. A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy. Front Oncol. 2023;13:1118371.
Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357(7):664–72.
Article CAS PubMed Google Scholar
Takahashi T, Yamanaka T, Seto T, Elaine R, Michael S, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017;18(5):663–71.
Pezzi TA, Fang P, Gjyshi O, Lei F, Suyu L, et al. Rates of overall survival and Intracranial Control in the magnetic resonance imaging era for patients with Limited-Stage Small Cell Lung Cancer with and without prophylactic cranial irradiation. JAMA Netw Open. 2020;3(4):e201929.
Article PubMed PubMed Central Google Scholar
Yan M, Toh TS, Lindsay PE, Jessica W, Katrina H, et al. Limited-stage small cell lung cancer: outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre. Clin Transl Radiat Oncol. 2021;30:43–9.
CAS PubMed PubMed Central Google Scholar
Pan L, Fan X, Wang L, Yihua W, Yaqi L, et al. Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the magnetic resonance imaging era. Cancer Med. 2023;12(3):2484–92.
Article CAS PubMed Google Scholar
Li J, Ding C, Yang C, Shuoshuo W, Xueying Q, et al. Prophylactic cranial irradiation confers favourable prognosis for patients with limited-stage small cell lung cancer in the era of MRI: a propensity score-matched analysis. J Med Imaging Radiat Oncol. 2021;65(6):778–85.
Chen Y, Wang Y, Ren F, Zhaoqin H, Bingxu T, et al. Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study. Respir Res. 2022;23(1):274.
Article CAS PubMed PubMed Central Google Scholar
Qi C, Li W, Li H, Fengyun W, Lu Z, et al. Benefits of prophylactic cranial irradiation in the MRI era for patients with Limited Stage Small Cell Lung Cancer. Front Oncol. 2022;12:833478.
Article PubMed PubMed Central Google Scholar
Farris MK, Wheless WH, Hughes RT, Michael HS, Adrianna HM, et al. Limited-Stage Small Cell Lung Cancer: is prophylactic cranial irradiation necessary? Pract Radiat Oncol. 2019;9(6):e599–607.
Farooqi AS, Holliday EB, Allen PK, Xiong W, James DC, et al. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: do all patients benefit? Radiother Oncol. 2017;122(2):307–12.
Article PubMed PubMed Central Google Scholar
Held MK, Hansen O, Schytte T, Karin HH, Rana B, et al. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain. Acta Oncol. 2022;61(2):185–92.
Article CAS PubMed Google Scholar
Liu J, Shen B, Yang Y, Jiayi G, Wei R, et al. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis. Acta Oncol. 2023;62(3):305–14.
Article CAS PubMed Google Scholar
Eze C, Roengvoraphoj O, Niyazi M, Guido H, Rainer F, et al. Treatment response and prophylactic cranial irradiation are prognostic factors in a real-life limited-disease small-cell Lung Cancer Patient Cohort comprehensively staged with cranial magnetic resonance imaging. Clin Lung Cancer. 2017;18(4):e243–9.
Simó M, Vaquero L, Ripollés P, Ane G, Josep J, et al. Longitudinal brain changes Associated with prophylactic cranial irradiation in Lung Cancer. J Thorac Oncol. 2016;11(4):475–86.
Gui C, Chintalapati N, Hales RK, Khinh R, Haris IS, et al. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer. J Neurooncol. 2019;144(2):351–8.
Article CAS PubMed Google Scholar
Rodríguez de Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, et al. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. J Clin Oncol.2021;39(28):3118–3127.
Belderbos JSA, De Ruysscher DKM, De Jaeger K, Friederike K, Maarten L, et al. Phase 3 Randomized Trial of prophylactic cranial irradiation with or without Hippocampus Avoidance in SCLC (NCT01780675). J Thorac Oncol. 2021;16(5):840–9.
Rusthoven CG, Yamamoto M, Bernhardt D, Derek ES, Dexiang G, et al. Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study. JAMA Oncol. 2020 Jul 1;6(7):1028-37.
Gaebe K, Li AY, Park A, et al. Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis. Lancet Oncol. 2022 Jul;23(7):931-9.
Ozawa Y, Omae M, Fujii M, Takashi M, Masato K, et al. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. BMC Cancer. 2015;15:589.
留言 (0)